First 18F-labeled ligand for PET imaging of uPAR: In vivo studies in human prostate cancer xenografts-Reference-Cited by-同舟云学术

First 18F-labeled ligand for PET imaging of uPAR: In vivo studies in human prostate cancer xenografts

Published:2013-07 Issue:5 Volume:40 Page:618-624
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Persson Morten,Liu Hongguang,Madsen Jacob,Cheng Zhen,Kjaer Andreas

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference29 articles.

1. Intact and cleaved uPAR forms: diagnostic and prognostic value in cancer;Rasch;Front Biosci,2008

2. Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer;Miyake;Prostate,1999

3. Elevation of urokinase-type plasminogen activator and its receptor densities as new predictors of disease progression and prognosis in men with prostate cancer;Miyake;Int J Oncol,1999

4. Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum;Piironen;Clin Chem,2006

5. Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy;Steuber;Int J Cancer,2007

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiochemistry with {Al18F}2+: Current status and optimization perspectives for efficient radiofluorination by complexation;Coordination Chemistry Reviews;2023-04

2. A novel urokinase plasminogen activator receptor-targeted peptide-based probe for in-vivo molecular imaging of glioblastoma;Nuclear Medicine Communications;2022-12-16

3. Preparation and Evaluation of [18F]AlF-NOTA-NOC for PET Imaging of Neuroendocrine Tumors: Comparison to [68Ga]Ga-DOTA/NOTA-NOC;Molecules;2022-10-12

4. In vivo detection of urokinase-type plasminogen activator receptor (uPAR) expression in arterial atherogenesis using [64Cu]Cu-DOTA-AE105 positron emission tomography (PET);Atherosclerosis;2022-07

5. Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer;Cancers;2022-01-19